Hilti Transforms Supply Chain Planning with Blue Yonder
Global company implemented Blue Yonder’s S&OP solution to enhance its integrated business planning process, improving…
News
Rezolute, Inc. Announces Aggregate $130 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
REDWOOD CITY, Calif., May 01, 2022 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage…
C3.AI 48 HOUR DEADLINE ALERT: ClaimsFiler Reminds Investors With Losses in Excess Of $100,000 of Deadline in Class Action Lawsuit Against C3.ai, Inc. – AI
NEW ORLEANS, La.–(BUSINESS WIRE)–ClaimsFiler, a FREE shareholder information service, reminds investors that they have only…
First Internet Bancorp Announces Termination of First Century Merger Agreement
FISHERS, Ind.–(BUSINESS WIRE)–First Internet Bancorp (the “Company”) (Nasdaq: INBK), the parent company of First Internet…
Adverum Biotechnologies Presents Additional Efficacy and Safety Data from the OPTIC Trial of ADVM-022 in Wet AMD at the ARVO 2022 Annual Meeting
– Poster highlights analysis of baseline neutralizing antibodies to AAV.7m8 and impact on ADVM-022 efficacy…
Rezolute Announces Positive Data from its Phase 2b (RIZE) Study of RZ358 in Patients with Congenital Hyperinsulinism
Results Presented Today at the Pediatric Endocrine Society’s 2022 Annual Meeting Highly significant ~75% reduction…
Kala Pharmaceuticals to Present Clinical Data for KPI-012, its Mesenchymal Stem Cell Secretome Product, for the Treatment of PCED at the 2022 ARVO Annual Meeting
— Data Demonstrate Rapid and Complete Wound Healing, with Six of Eight (75%) Patients Achieving…
Ascendis Pharma A/S to Present New Endocrinology Results at Four Medical Meetings in May
New data highlights include: – Phase 3 open-label extension study data for growth hormone-deficient children treated…
GoodDollar Sets Out Ambitious New Roadmap
Tel Aviv, Israel–(Newsfile Corp. – May 1, 2022) – GoodDollar, an anti-poverty protocol and DAO…
The Milken Institute Celebrates 25th Global Conference May 1-4
The four-day, in-person event features more than 800 speakers, including government officials, Oscar winners, philanthropists,…
GemPad Has Been Successfully Listed on CoinMarketCap with New Platforms Available on Launchpad, New Features, Special Sale and Tier Structure
Dublin, Ireland–(Newsfile Corp. – April 30, 2022) – GemPad has been listed on CoinMarketCap (CMC)…
LBank Exchange Will List Dingocoin (DINGO) on May 5, 2022
Internet City, Dubai–(Newsfile Corp. – April 30, 2022) – LBank Exchange, a global digital asset…
LBank Exchange Will List Super Kids (KIDS) on May 5, 2022
Internet City, Dubai–(Newsfile Corp. – April 30, 2022) – LBank Exchange, a global digital asset…
Hawaii-Based Oceanit to Bring Sweeping Disruptive Innovation to Houston, Global Energy Transformation
Oceanit’s EDGE (Energy & Decarbonization for the Global Environment) launch coincides with OTC2022 (Offshore Technology…
Saniona publishes its Annual Report for 2021
PRESS RELEASE April 30, 2022 Saniona (OMX: SANION), a clinical–stage biopharmaceutical company focused on rare…
Tarsus to Host Webcast to Review Topline Results from Saturn-2 Phase 3, the Second Pivotal Trial of TP-03 for the Treatment of Demodex Blepharitis
IRVINE, Calif., April 29, 2022 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission…
Intellabridge Technology Corporation Announces Change of Company Auditor, Change of Year End, and Filing of Restated Financial Statements for the Years Ended December 31, 2018 and December 31, 2019
Menlo Park, California and Vancouver, British Columbia–(Newsfile Corp. – April 29, 2022) – Intellabridge Technology…
C3.AI 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against C3.ai, Inc. – AI
NEW ORLEANS–(BUSINESS WIRE)–Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General…
Procaps Group Reports Fourth Quarter and Fiscal Year 2021 Financial Results
Fiscal Year 2021 Net Revenues Increased 23.6% to $409.7 Million, with Adjusted EBITDA Up 17.8%…
Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults
First novel, nonstimulant option for adults with ADHD in 20 years ADHD affects an estimated…